NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10477.30 -216.40 -2.02%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nicox (EPA: COX)

 

COX Share Price

Open 8.80 Change Price %
High 8.98 1 Day 0.07 0.80
Low 8.77 1 Week 0.00 0.00
Close 8.86 1 Month -0.50 -5.34
Volume 69616 1 Year 1.11 14.32
52 Week High 13.68
52 Week Low 7.35
 
COX Technical Analysis
3
As on 1st Nov 2017 COX Share Price closed @ 8.86 and we RECOMMEND Sell for LONG-TERM with Stoploss of 9.74 & Sell for SHORT-TERM with Stoploss of 9.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
VK 4.72 0.43%
ALALO 0.04 0.00%
CS 26.31 1.47%
TEC 67.40 0.40%
ACA 14.98 0.00%
ALAUP 0.20 -13.04%
 
EPA France Top Gainers Stocks
MLFCI 0.31 34.78%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
ALFRE 1.81 25.69%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
 
EPA France Top Losers Stocks
MLROU 6.37 -34.19%
MLLEA 0.61 -23.75%
ALAUP 0.20 -13.04%
OXI 0.08 -11.11%
OXI 0.08 -11.11%
MLFXO 3.79 -9.98%
TONN 1.20 -9.77%
ALCLS 26.88 -9.22%
RUSAL 10.00 -9.09%
ALEUP 0.20 -9.09%
 
 
COX
Daily Charts
COX
Intraday Charts
Whats New @
Bazaartrend
COX
Free Analysis
 
COX Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE9.05
RESISTANCE8.97
SUPPORT8.75
SUPPORT8.67
SUPPORT0.00
SUPPORT0.00
 
COX Target for Month December
4th UP TARGET11.52
3rd UP TARGET10.65
2nd UP TARGET10.12
1st UP TARGET9.58
1st DOWN TARGET8.06
2nd DOWN TARGET7.52
3rd DOWN TARGET6.99
4th DOWN TARGET6.12
 
COX Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
COX Target for Year 2018
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
COX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.nicox.com
 
COX Address
COX
Drakkar 2 - B
2405 route des Dolines
Sophia Antipolis, 06906
France
Phone: 33 4 97 24 53 00
Fax: 33 4 97 24 53 99
 
COX Latest News
 
Your Comments and Response on Nicox
 
COX Business Profile
NicOx S.A. develops a portfolio of therapies and diagnostic tools to enhance sight in the United States, Europe, and internationally. It provides AdenoPlus a diagnostic test that offers eyecare professionals to diagnose and manage patients with an acute red eye. The company’s pipeline product, Latanoprostene bunod, is in Phase III clinical trials for the treatment of glaucoma and ocular hypertension. In addition, it is engaged in the research and development of nitric oxide steroids for the treatment of back and front of the eye disease; and NO-donors for eye disorder applications. Further, the company develops Naproxcinod, an anti-inflammatory candidate that is in regulatory review with the US Food and Drug Administration for the treatment of signs and symptoms of osteoarthritis; nitric oxide for cardiovascular indications; and NCX 1047, a dermatology anti-inflammatory drug-candidate, which is in preclinical stage of development. NicOx S.A. has collaboration with Bausch + Lomb, Merck, and Grupo Ferrer Internacional S.A. The company was founded in 1996 and is headquartered in Sophia Antipolis, France.
 
2005-2018 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service